Eli Lilly and Company · Q4 2024
ReportedFeb 6, 2025
Period endedDec 31, 2024
The quarter in short
Revenue $13.53B, up 18.3% on the quarter. EPS $4.88, up 356.1% on the quarter. Free cash flow $978M, down 58.6% on the quarter.
Reported this quarter
Revenue
$13.53B
QoQ +18.3%
YoY —
EPS
$4.88
QoQ +356.1%
YoY —
Free Cash Flow
$978M
QoQ −58.6%
YoY —
Gross Margin
82.2%
QoQ +1.2 pp
YoY —
FCF Margin
7.2%
QoQ −13.4 pp
YoY —
P/E Ratio
65.6
QoQ −31.1%
YoY —
Each tile opens the full quarterly series. Download the numbers as CSV or JSON.
Sources & downloads
Company
Published by the company on the day of the release.
HTML
Earnings press release
Investor relations announcement
SEC filings
Filed with the SEC under CIK 59478.
HTML
8-K results announcement
Filed Feb 6, 2025
HTM
Press release (EX-99.1)
Exhibit 99.1 to the 8-K
211 KB
HTML
Filing index
Every document in the 8-K submission
TXT
Complete submission
Raw archival text of the whole filing
HTML
10-K annual report
Period ended Dec 31, 2024, filed Feb 19, 2025
ZIP
XBRL data bundle
Structured financial statements from the 10-K
JSON
Company facts (XBRL)
Every figure LLY has reported to the SEC
R40 data
The numbers shown on this page, as we hold them.
CSV
This quarter (CSV)
Reported metrics for Q4 2024, spreadsheet-ready
JSON
This quarter (JSON)
Metrics, dates and matched filings